CTMX · All filings · Read this filing
What changed 10-Q
Item 5. Other Information
2022-05-05 compared with 2021-11-04 · 1 added, 4 removed, 28 unchanged (15% of the section changed)
7 unchanged sentences
Specimen Common Stock Certificate
−Removed: Description of Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934.
Certification of Chief Executive Officer required by Rule 13a-14(a) or Rule 15d-14(a).
13 unchanged sentences
CytomX Therapeutics, Inc.
−Removed: November 4, 2021
−Removed: President, Chief Executive Officer and Director
+Added: Chief Executive Officer and Chairman
(Principal Executive Officer)
−Removed: November 4, 2021
/s/ Carlos Campoy
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.